Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 34Melanoma 13Carcinoma, Hepatocellular 13Neoplasm Metastasis 12Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Neoplasms 9Esophageal Neoplasms 9Colorectal Neoplasms 6Esophageal Squamous Cell Carcinoma 5Breast Neoplasms 5Recurrence 4Rectal Neoplasms 4Brain Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Sarcoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Liver Neoplasms 3Head and Neck Neoplasms 3Cholangiocarcinoma 3Carcinoma, Renal Cell 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Radiation Pneumonitis 2Prostatic Neoplasms 2Pathologic Complete Response 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroblastoma 2

Interventions

Diathermy 20Radiotherapy 10Cisplatin 5Fluorouracil 4Drug Therapy 4Radiation 3Melphalan 3Immune Checkpoint Inhibitors 3Cytoreduction Surgical Procedures 3Brachytherapy 3tislelizumab 2Solutions 2Immunotherapy 2Hyperthermia, Induced 2Hydrogen Peroxide 2Doxorubicin 2Conization 2Capecitabine 2spartalizumab 1sodium thiosulfate 1anlotinib 1Temozolomide 1Surgical Procedures, Operative 1Saline Solution 1Radiation Dose Hypofractionation 1Paclitaxel 1Oxaliplatin 1Mitomycin 1Leucovorin 1Laser Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Hyperthermia × Immunotherapy × Clear all
NCT07118566 2025-08-12

Hyperthermia Combined With Immune Checkpoint Inhibitors in the Treatment of Advanced Gastrointestinal Malignancies With Liver Metastases

China Medical University, China

Phase 2 Not yet recruiting
40 enrolled
Gastrointestinal

Hyperthermia, Gastrointestinal Neoplasms

NCT06249750 2024-02-08

Clinical Application of Near-infrared Whole Body Heat Shock Multimodal Technique in Treatment of Castration-resistant Prostate Cancer

Zhejiang Hospital

Phase 2 Recruiting
60 enrolled

Hyperthermia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡